The Woodlands, TX, United States of America

Gregory M Landes

USPTO Granted Patents = 19 

 

 

Average Co-Inventor Count = 7.7

ph-index = 7

Forward Citations = 178(Granted Patents)


Location History:

  • San Mateo, CA (US) (2011)
  • The Woodlands, TX (US) (2010 - 2017)
  • San Bruno, CA (US) (2013 - 2022)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Loading Chart...
19 patents (USPTO):Explore Patents

Title: Gregory M Landes: Innovator in Anti-CD38 Therapeutics

Introduction

Gregory M Landes, based in The Woodlands, TX, is a prolific inventor with a remarkable portfolio of 19 patents. His work primarily focuses on the development of innovative therapies for treating multiple myeloma, a type of blood cancer.

Latest Patents

Among his latest contributions to the field are his patents for Anti-CD38 binding domains. This innovation includes a composition comprising these binding domains, along with nucleic acids that encode them. Furthermore, it outlines methods for utilizing these binding domains or the composition for treating multiple myeloma. Another significant patent involves Anti-CD38 antibodies, which details isolated antibodies that specifically bind to human CD38 and cynomolgus CD38. This patent also covers pharmaceutical compositions that incorporate these antibodies and methods for their therapeutic and diagnostic use.

Career Highlights

Gregory M Landes has made significant strides in the pharmaceutical industry through his positions at notable companies. He has worked with Takeda Pharmaceutical Company Limited and Lexicon Pharmaceuticals, Inc., where he contributed to the advancement of pharmaceutical innovations.

Collaborations

In addition to his own achievements, Landes has collaborated with esteemed professionals, including Kathleen Ann Elias and Wouter Korver. These collaborations have fostered the development of groundbreaking therapies and enriched the research landscape in the field of oncology.

Conclusion

Gregory M Landes exemplifies the spirit of innovation in biotechnology. His contributions to anti-CD38 therapies have the potential to significantly impact the treatment of multiple myeloma, showcasing his dedication to advancing medical science for patients in need. With a robust patent portfolio and a strong collaborative network, Landes continues to be a key figure in the fight against cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…